Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer
Abstract The detection of circulating cell-free DNA (cfDNA) by liquid biopsy is reported to provide prognostic information in colorectal cancer (CRC). Although the frequency of BRAF V600E mutation in CRC is less than 10%, it is associated with poor responses to conventional chemotherapy. We conducte...
Guardado en:
Autores principales: | Keita Tanaka, Yoichiro Yoshida, Teppei Yamada, Takaomi Hayashi, Hideki Shimaoka, Fumihiro Yoshimura, Ryuji Kajitani, Taro Munechika, Yoshiko Matsumoto, Hideki Nagano, Akira Komono, Ryohei Sakamoto, Ryo Nakashima, Naoya Aisu, Gumpei Yoshimatsu, Suguru Hasegawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d9438e0d8b04f329885f76dfce1bab6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
por: Kavish Kohabir, et al.
Publicado: (2021) -
Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer
por: Kazutaka Fujita, et al.
Publicado: (2021) -
Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patients
por: Elmo W. I. Neuberger, et al.
Publicado: (2021) -
Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients
por: Xiaorong Zhou, et al.
Publicado: (2021) -
Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA
por: Thomas L. Dunwell, et al.
Publicado: (2021)